Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Daphne S. Bakker's publication output changed over time?
ScholarIQpublication output · 2018–2023
Output grew100% over the shown period — from 1 works in 2018 to 2 in 2023.
1
2
3
2
1
2
201820192020202120222023
What are the most-cited papers on Daphne S. Bakker?
ScholarIQmost cited works
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Daphne S. Bakker, Lieneke F.M. Ariëns, C. van Luijk, Jorien van der Schaft, Judith L. Thijs, Marie L. A. Schuttelaar, Femke van Wijk, Edward F. Knol, Deepak M.W. Balak, Marijke R. van Dijk, Marjolein de Bruin‐Weller
British Journal of Dermatology. 2018154 CitationsOPEN ACCESS
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Deepak M.W. Balak, Margreet L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia C. A. van Amerongen, Evelien M. Delemarre, Edward F. Knol, Femke van Wijk, Stefan Nierkens, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller
Allergy. 2019150 CitationsOPEN ACCESS
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Daphne S. Bakker, Stefan Nierkens, Edward F. Knol, Barbara Giovannone, Eveline M. Delemarre, Jorien van der Schaft, Femke van Wijk, Marjolein de Bruin‐Weller, Julia Drylewicz, Judith L. Thijs
Journal of Allergy and Clinical Immunology. 2020124 CitationsOPEN ACCESS
Biomarkers in atopic dermatitis
Daphne S. Bakker, Marjolein de Bruin‐Weller, Julia Drylewicz, Femke van Wijk, Judith L. Thijs
Journal of Allergy and Clinical Immunology. 2023107 CitationsOPEN ACCESS
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst, Daphne S. Bakker, Geertruida L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Angelique N. Voorberg, Albert J. Oosting, Ilona de Ridder, Annemieke Sloeserwij, Inge Haeck, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller
S58727509. 202093 CitationsOPEN ACCESS
Related on ScholarIQ
Utrecht University
Institution
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Paper
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Paper
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Paper
Biomarkers in atopic dermatitis
Paper
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
Paper